Treatment modalities for patients with low grade glioma (LGG) WHO grade II are controversial. Overall survival ranges from 2 to over 15 years depending on molecular and clinical factors. Hence, risk a
Additional file 5: Table S5. Association of GR methylation groups (based on methylation of C and U promoter regions) and clinical characteristics in MA.12 GR methylation study patients.